Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Stocks
Immunovant, Inc.
Business Segments
Business Segments
Net loss
Net loss
Immunovant, Inc.
·
Business Segments
·
1 segment
·
Rolls up to
Net Income
Breakdown
Segments
Business Segments
View metric
Quarterly
Annual
TTM
Segment
Q4 '26
Business Segments
$147.86M
Total
-$147.86M